Medtronic plc
MDT
Rang in aandelen
#185
Medtronic plc is a leading global medical technology enterprise that invents,... Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
Aandeelprijs
$93.86
Marktkapitalisatie
$120.06B
Verandering (1 dag)
0.98%
Verandering (1 jaar)
-2.15%
Land
IE
Handel Medtronic plc (MDT)
Categorie
Healthcare
Winst voor Medtronic plc (MDT)
Winst in Jan 2026 TTM: $5.56B
Volgens de meest recente financiële verslagen van Medtronic plc bedraagt de huidige winst van het bedrijf $5.56B. In 2024 behaalde het bedrijf een winst van $4.84B, een daling ten opzichte van de winst van 2023, die $5.36B bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Medtronic plc van 2000 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $5.56B | -1.15% |
| 2025 | $5.63B | 16.35% |
| 2024 | $4.84B | -9.82% |
| 2023 | $5.36B | -2.77% |
| 2022 | $5.52B | 41.64% |
| 2021 | $3.90B | -3.95% |
| 2020 | $4.06B | -21.97% |
| 2019 | $5.20B | -8.42% |
| 2018 | $5.68B | 23.32% |
| 2017 | $4.60B | 6.13% |
| 2016 | $4.34B | 24.38% |
| 2015 | $3.49B | -5.91% |
| 2014 | $3.71B | -12.84% |
| 2013 | $4.25B | 2.56% |
| 2012 | $4.15B | 13.13% |
| 2011 | $3.66B | -7.10% |
| 2010 | $3.94B | 61.64% |
| 2009 | $2.44B | -15.42% |
| 2008 | $2.89B | -17.92% |
| 2007 | $3.52B | 11.20% |
| 2006 | $3.16B | 24.25% |
| 2005 | $2.54B | -9.04% |
| 2004 | $2.80B | 19.46% |
| 2003 | $2.34B | 53.61% |
| 2002 | $1.52B | -1.63% |
| 2001 | $1.55B | -4.05% |
| 2000 | $1.61B | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $7.51B | 35.02% |
US
|
|
| $5.15B | -7.46% |
US
|
|
| $3.86B | -30.60% |
US
|
|
| - | - |
DE
|
|
| $1.42B | -74.52% |
US
|
